Welcome to StemCyte India
StemCyte India Therapeutics Pvt. Ltd. (StemCyte India) was born on the 1st Vibrant Gujarat Summit held in 2007, spearheaded by Honorable Prime Minister Shri Narendra Modi.
StemCyte India is a joint venture between StemCyte Inc. (USA), Apollo Hospital Enterprises Ltd., and Cadila Pharmaceuticals Ltd. StemCyte India’s headquarter and processing facility is strategically located in Gujarat state (The hub of Thalassemia and Sickle Cell Anemia).
PILLARS
Your baby’s cord blood is a rich source of stem cells, the building blocks of our bodies, which acts as a “Self-repair Kit”.Your baby’s cord blood is a rich source of stem cells, the building blocks of our bodies, which acts as a “Self-repair Kit”.
PROMISING
Cord blood stem cells hold the power to cure over 80 diseases and the research is going on for many other diseases.Cord blood stem cells hold the power to cure over 80 diseases and the research is going on for many other diseases.
PRECIOUS
Cord blood stem cells are genetically unique and are a 100% match for the same child and may be a match for other family members.Cord blood stem cells are genetically unique and are a 100% match for the same child and may be a match for other family members.
StemCyte Differentiator
‘Hybrid+’ Model
One extra unit free from StemCyte’s public repository.
Plasma Depletion Technique
StemCyte’s patented Plasma Depletion technique ensures 99.96% stem cell recovery.
High Quality & Standards
StemCyte is one of the most internationally certified cord blood bank for both private & public cord blood units.
Clinical Trials & Research
StemCyte is committed to rigorous clinical trials to develop new indications.
StemCyte’s International Experts
StemCyte’s International Experts are working on various potential diseases.
Transplant Experience
StemCyte has facilitated as many as 2200 umbilical cord blood transplants worldwide.
IN INDIA
